CARLSBAD, Calif., Feb. 28,
2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) today announced that management will present at the
following investor conferences:
- Cowen 43rd Annual Health Care Conference on
Tuesday, March 7, 2023
- Oppenheimer 33rd Annual Virtual Healthcare
Conference on Wednesday, March 15,
2023
- Stifel 2023 Virtual CNS Days on Wednesday, March 29, 2023
A live webcast of the presentations can be accessed on the
Investors & Media section of the Ionis website at
www.ionispharma.com. The replay will be available on the Ionis
website within 48 hours and will be archived for a limited
time.
About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted
therapy, pioneering new markets and changing standards of care with
its novel antisense technology. Ionis currently has three marketed
medicines and a premier late-stage pipeline highlighted by
industry-leading cardiovascular and neurological franchises. Our
scientific innovation began and continues with the knowledge that
sick people depend on us, which fuels our vision of becoming the
leader in genetic medicine, utilizing a multi-platform approach to
discover, develop and deliver life-transforming therapies.
To learn more about Ionis, visit www.ionispharma.com and follow
us on Twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301757230.html
SOURCE Ionis Pharmaceuticals, Inc.